Small molecules, life-changing power.
A biotech company developing novel oral small molecule therapies for underserved rare diseases.
ABOUT ALESTA
Our globally experienced team brings together diverse expertise to drive small molecule innovation, developing targeted and effective therapies for rare diseases where few options exist. With a patient-friendly approach, we prioritize safety, efficacy, and accessibility. Ensuring every step of development reflects both scientific excellence and patient trust.
Global
Expertise
Our team combines deep experience and global talent across all functions, ensuring the right people are always at the table.
We prioritize thoughtful drug development with safety, efficacy, and accessibility at the forefront, ensuring treatments are suitable for all age groups and easy to use.
Patient-friendly Approach
Small Molecule Innovation
Small molecule innovation combines scientific precision with practical accessibility, providing targeted, effective therapies for rare diseases where few treatments exist.
Transparent Engagement
We engage with patients from the start to understand their needs and challenges, and communicate openly about our commitment and development milestones.
SMALL MOLECULE INNOVATION
Small molecules are favored in rare diseases because they combine practical advantages such as oral delivery, scalability, and cost-effectiveness with scientific strengths like deep tissue penetration and precise targeting making them ideal for chronic, multisystemic conditions where access and patient convenience are essential.
